Europe urged to adapt faster to gene therapy challenges
Resistance to high prices, even with novel payment models Europe’s leading nations should commit to a rapid overhaul of health technology assessment (HTA) and bold initiatives such as new pan-European real world evidence (RWE) frameworks, in order to nurture the nascent cell and gene therapy revolution in the region. That is the conclusion of a